Holen Sie sich die Stockscreener-App
71.10
4.14%
-3.07
Handel nachbörslich:
67.85
-3.25
-4.57%
Schlusskurs vom Vortag:
$74.17
Offen:
$72.58
24-Stunden-Volumen:
1.11M
Relative Volume:
1.34
Marktkapitalisierung:
$7.49B
Einnahmen:
$628.56M
Nettoeinkommen (Verlust:
$141.82M
KGV:
56.43
EPS:
1.26
Netto-Cashflow:
$142.60M
1W Leistung:
-0.64%
1M Leistung:
-19.34%
6M Leistung:
-2.29%
1J Leistung:
+42.03%
1-Tages-Spanne:
$69.68
$73.69
1-Wochen-Bereich:
$69.68
$74.27
52-Wochen-Spanne:
$49.00
$117.33
Corcept Therapeutics Inc Stock (CORT) Company Profile
Firmenname
Corcept Therapeutics Inc
Sektor
Branche
Telefon
650.688.8803
Adresse
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Vergleichen Sie CORT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
71.10 | 7.82B | 628.56M | 141.82M | 142.60M | 1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-11-06 | Hochstufung | Truist | Hold → Buy |
| 2023-04-11 | Eingeleitet | SVB Securities | Market Perform |
| 2023-04-04 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-15 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-01 | Herabstufung | Truist | Buy → Hold |
| 2022-07-27 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-27 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-02-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-01-28 | Eingeleitet | Truist | Buy |
| 2020-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2019-09-24 | Eingeleitet | Jefferies | Buy |
| 2019-09-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-02-04 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2018-08-10 | Bestätigt | Stifel | Hold |
| 2018-05-31 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-09 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-08-31 | Eingeleitet | Stifel | Buy |
| 2017-02-02 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2015-04-21 | Eingeleitet | FBR Capital | Outperform |
| 2014-01-13 | Herabstufung | Stifel | Buy → Hold |
| 2013-08-09 | Herabstufung | Janney | Buy → Neutral |
| 2013-08-09 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2012-02-21 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-01-06 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2008-07-17 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
| 2007-06-21 | Hochstufung | Punk, Ziegel & Co | Mkt Perform → Accumulate |
Alle ansehen
Corcept Therapeutics Inc Aktie (CORT) Neueste Nachrichten
Corcept Therapeutics Inc (CORT) Q3 2025 Earnings Call Highlights: Revenue Growth Amidst Net Income Decline - GuruFocus
Decoding Corcept Therapeutics Inc (CORT): A Strategic SWOT Insig - GuruFocus
Corcept Therapeutics Reports Q3 Growth and Expands Oncology Programs - TipRanks
Corcept Therapeutics Misses Revenue Targets, Ups Future Guidance - Finimize
Corcept Therapeutics (CORT) Q3 Earnings and Revenues Miss Estimates - Yahoo Finance
Corcept (NASDAQ:CORT) Reports Sales Below Analyst Estimates In Q3 Earnings - TradingView
Corcept: Q3 Earnings Snapshot - News-Times
Corcept Therapeutics (CORT) Adjusts 2025 Revenue Forecast Amid G - GuruFocus
Corcept Therapeutics misses Q3 revenue expectations, modifies 2025 revenue forecast - MarketScreener
Corcept Therapeutics Inc Q3 Earnings: EPS of $0.16 Beats Estimat - GuruFocus
Corcept Therapeutics (NASDAQ: CORT) updates 2025 guidance to $800–$850M - Stock Titan
What Does Wall Street Think About Corcept Therapeutics (CORT)? - Yahoo Finance
Risk vs reward if holding onto Corcept Therapeutics IncorporatedJuly 2025 Momentum & Low Risk Investment Opportunities - newser.com
Is Corcept Therapeutics Incorporated stock positioned well for digital economy2025 Earnings Surprises & Stepwise Trade Signal Guides - newser.com
Will Corcept Therapeutics Incorporated stock recover after recent dropInsider Buying & Breakout Confirmation Trade Signals - newser.com
Will a bounce in Corcept Therapeutics Incorporated offer an exit2025 Investor Takeaways & Daily Technical Stock Forecast Reports - newser.com
What hedge fund moves indicate for Corcept Therapeutics Incorporated (HTD) stockQuarterly Trade Report & Low Risk Entry Point Guides - newser.com
Corcept Therapeutics Incorporated $CORT Shares Sold by Assetmark Inc. - MarketBeat
Will Corcept Therapeutics Incorporated (HTD) stock return to pre crash levelsEarnings Summary Report & Daily Stock Momentum Reports - newser.com
How Corcept Therapeutics Incorporated stock compares to growth peersWeekly Loss Report & Long-Term Capital Growth Strategies - newser.com
Using data models to predict Corcept Therapeutics Incorporated stock movementWeekly Trade Analysis & Consistent Income Trade Ideas - newser.com
Is Corcept Therapeutics Incorporated stock affected by interest rate hikes2025 AllTime Highs & Low Drawdown Investment Strategies - newser.com
Is Corcept Therapeutics Incorporated (HTD) stock a top pick for value investorsMarket Rally & Long-Term Safe Investment Ideas - newser.com
Does Corcept Therapeutics Incorporated qualify in momentum factor screeningMarket Sentiment Summary & Reliable Entry Point Alerts - newser.com
Is Corcept Therapeutics Incorporated (HTD) stock inflation resilient2025 Historical Comparison & Stock Portfolio Risk Management - newser.com
Is Corcept Therapeutics Incorporated (HTD) stock undervalued at current priceMarket Activity Recap & Long-Term Growth Portfolio Plans - newser.com
Will Corcept Therapeutics Incorporated (HTD) stock enhance shareholder valueJuly 2025 Movers & Real-Time Volume Analysis - newser.com
Detecting support and resistance levels for Corcept Therapeutics IncorporatedJuly 2025 Action & Long-Term Growth Stock Strategies - newser.com
Is Corcept Therapeutics Incorporated stock attractive for income investors2025 Geopolitical Influence & Weekly High Momentum Picks - newser.com
How hedge fund analytics apply to Corcept Therapeutics Incorporated stockJuly 2025 Decliners & Fast Exit and Entry Strategy Plans - newser.com
How high can Corcept Therapeutics Incorporated stock go2025 Trade Ideas & Weekly Hot Stock Watchlists - newser.com
Corcept Earnings: What To Look For From CORT - The Globe and Mail
Key metrics from Corcept Therapeutics Incorporated’s quarterly data2025 Retail Activity & Target Return Focused Stock Picks - newser.com
Corcept Therapeutics Incorporat (CORT) stock forecast and price target - Yahoo! Finance UK
Does Corcept Therapeutics Incorporated (HTD) stock trade below intrinsic valueJuly 2025 Summary & Risk Managed Investment Signals - newser.com
Y Intercept Hong Kong Ltd Purchases 11,881 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Building trade automation scripts for Corcept Therapeutics IncorporatedDay Trade & Precise Buy Zone Tips - newser.com
What momentum indicators show for Corcept Therapeutics Incorporated stockPortfolio Risk Report & Weekly Chart Analysis and Trade Guides - newser.com
Using Bollinger Bands to evaluate Corcept Therapeutics IncorporatedJobs Report & Daily Entry Point Trade Alerts - newser.com
Corcept Therapeutics Inc expected to post earnings of 14 cents a shareEarnings Preview - TradingView
Finanzdaten der Corcept Therapeutics Inc-Aktie (CORT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):